The Aesthetics adheres completely to the ethical guidelines for research and publication described in Guidelines on Good Publication(http://publicationethics.org/resources/guidelines), Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) and the Principles of Transparency and Best Practice in Scholarly Publishing (http://doaj.org/bestpractice). For issues not addressed in theses instructions, the author is referred to the International Committee of Medical Journal Editors (ICMJE) "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" (http://www.icmje.org/icmje-recommendations.pdf).
All authors of a manuscript must have agreed to its submission and are responsible for its content, including appropriate citations and acknowledgements; they must also have agreed that the corresponding author has the authority to act on their behalf on all matters pertaining to the publication of the paper. By publishing in this journal, the authors agree that the Korean Geriatrics Society has the right to protect the manuscript from misappropriation. Illustrations in published articles will not be returned to the authors.

The Aesthetics accepts advertising and sponsorship for its printed journal according to the following principles:

• Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
• The Aesthetics reserves the right to decline or cancel any advertisement at any time.
• Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

All published papers become the permanent property of the Korean Association for Laser, Dermatology and Trichology. Copyrights of all published materials are owned by the Korean Association for Laser, Dermatology and Trichology. Permission must be obtained from the Korean Association for Laser, Dermatology and Trichology for any commercial use of materials. Every author should sign the copyright transfer agreement forms. This journal is owned by the publisher, the Korean Association for Laser, Dermatology and Trichology (http://www.theaesthetics.org/).

Redundant publication is defined as "reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)".Characteristics of reports that are substantially similar include the following: (a) "at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication)," (b) "the subject or study populations are often the same or similar," (c) "the methodology is typically identical or nearly so," and (d) "the results and their interpretation generally vary little, if at all."
When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to Medical Lasers differs substantially from this other material. If all or part of your patient population was previously reported, this should be mentioned in the Materials and Methods, with citation of the appropriate reference(s).

According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive pre-print, i.e. pre-refereeing), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive publisher's version/PDF.

This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”. The ICMJE’s policy regarding trial registration is explained at
http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trialregistration.html#two. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.